Emtricitabine/Rilpivirine/Tenofovir Disoproxil Fumarate Single-Tablet Regimen: A Guide to Its Use in HIV-1 Infection

被引：0
|
作者：
Katherine A. Lyseng-Williamson
Lesley J. Scott
机构：
[1] Adis,
来源：
Clinical Drug Investigation | 2012年 / 32卷
关键词：
Efavirenz; Tenofovir Disoproxil Fumarate; Virological Failure; Emtricitabine; Etravirine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The once-daily, single-tablet regimen of emtricitabine/rilpivirine/tenofovir disoproxil fumarate (Eviplera™ [EU]; Complera™ [US]) provides a convenient option for antiretroviral therapy in treatment-naive patients with HIV-1 infection. In well designed trials in this patient population, rilpivirine plus emtricitabine/tenofovir disoproxil fumarate was noninferior to efavirenz plus emtricitabine/tenofovir disoproxil fumarate in terms of reducing viral HIV-1 RNA level to <50 copies/mL and was generally better tolerated than efavirenz plus emtricitabine/tenofovir disoproxil fumarate.
引用
收藏
页码：715 / 722
页数：7
相关论文
共 50 条
  • [21] Randomized, phase 2 evaluation of two single-tablet regimens elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate versus efavirenz/emtricitabine/tenofovir disoproxil fumarate for the initial treatment of HIV infection
    Cohen, Calvin
    Elion, Richard
    Ruane, Peter
    Shamblaw, David
    DeJesus, Edwin
    Rashbaum, Bruce
    Chuck, Steven L.
    Yale, Kitty
    Liu, Hui C.
    Warren, David R.
    Ramanathan, Srinivasan
    Kearney, Brian P.
    [J]. AIDS, 2011, 25 (06) : F7 - F12
  • [22] Hepatic Safety of Rilpivirine/Emtricitabine/Tenofovir Disoproxil Fumarate Fixed-Dose Single-Tablet Regimen in HIV-Infected Patients with Active Hepatitis C Virus Infection: The hEPAtic Study
    Neukam, Karin
    Espinosa, Nuria
    Collado, Antonio
    Delgado-Fernandez, Marcial
    Jimenez-Aguilar, Patricia
    Rivero-Juarez, Antonio
    Hontanon-Antonana, Victor
    Gomez-Berrocal, Ana
    Ruiz-Morales, Josefa
    Merino, Dolores
    Carrero, Ana
    Tellez, Francisco
    Jose Rios, Maria
    Hernandez-Quero, Jose
    de Lagarde-Sebastian, Maria
    Perez-Camacho, Ines
    Vera-Mendez, Francisco
    Macias, Juan
    Pineda, Juan A.
    [J]. PLOS ONE, 2016, 11 (05):
  • [23] Single-tablet regimen with elvitegravir, cobicistat, emtricitabine and tenofovir for the treatment of early HIV infection
    Teira, Ramon
    Galindo, Maria
    Montero, Marta
    Portilla, Raquel
    Ferrer, Ana
    Martinez, Elisa
    [J]. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2016, 19
  • [24] Budget impact analysis of introducing the new single-tablet regimen rilpivirine/emtricitabine/tenofovir for the treatment of HIV in Portugal
    Gouveia, M.
    Costa, J.
    Teofilo, E.
    Borges, M.
    [J]. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2012, 15 : 69 - 69
  • [25] Emtricitabine/Tenofovir Disoproxil Fumarate In Combination with a Protease Inhibitor in HIV-1 Infection
    Perry, Caroline M.
    [J]. DRUGS, 2009, 69 (07) : 843 - 857
  • [26] Switching to elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate single-tablet regimen (Stribild®): effects on T-cell compartment and HIV reservoirs
    Merlini, Esther
    Cazzaniga, Federico
    Casabianca, Anna
    Orlandi, Chiara
    Ancona, Giuseppe
    Cogliandro, Viola
    Tincati, Camilla
    Bini, Teresa
    Magnani, Mauro
    Monforte, Antonella d'Arminio
    Marchetti, Giulia
    [J]. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2016, 19
  • [27] A Randomized, Double-Blind Comparison of Single-Tablet Regimen Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Versus Single-Tablet Regimen Efavirenz/Emtricitabine/Tenofovir DF for Initial Treatment of HIV-1 Infection: Analysis of Week 144 Results
    Wohl, David A.
    Cohen, Calvin
    Gallant, Joel E.
    Mills, Anthony
    Sax, Paul E.
    DeJesus, Edwin
    Zolopa, Andrew
    Liu, Hui C.
    Plummer, Andrew
    White, Kirsten L.
    Cheng, Andrew K.
    Rhee, Martin S.
    Szwarcberg, Javier
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2014, 65 (03) : E118 - E121
  • [28] Stable Caloric Intake and Continued Virologic Suppression for HIV-Positive Antiretroviral Treatment-Experienced Women After Switching to a Single-Tablet Regimen of Emtricitabine, Rilpivirine, and Tenofovir Disoproxil Fumarate
    Menezes, Prema
    Mollan, Katie
    Hoffman, Erin
    Xie, Zimeng
    Wills, Jennifer
    Marcus, Cheryl
    Rublein, John
    Hudgens, Michael
    Eron, Joseph J., Jr.
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 2018, 34 (06) : 481 - 485
  • [29] Emtricitabine/rilpivirine/tenofovir-disoproxil-fumarateDevelopment of resistance in HIV-1 infection: case report
    [J]. Reactions Weekly, 2016, 1625 (1) : 88 - 88
  • [30] Abacavir/Dolutegravir/Lamivudine Single-Tablet Regimen: A Review of Its Use in HIV-1 Infection
    Sarah L. Greig
    Emma D. Deeks
    [J]. Drugs, 2015, 75 : 503 - 514
12345